You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study)
|
|---|---|
| Published in |
Infectious Diseases and Therapy, October 2021
|
| DOI | 10.1007/s40121-021-00543-2 |
| Pubmed ID | |
| Authors |
Aránzazu Sancho-López, Antonio F. Caballero-Bermejo, Belén Ruiz-Antorán, Elena Múñez Rubio, Mercedes García Gasalla, Juan Buades, Marta González Rozas, María López Veloso, Ana Muñoz Gómez, Ana Cuenca Abarca, Pedro Durán del Campo, Fátima Ibáñez, Alberto Díaz de Santiago, Yolanda Romero, Jorge Calderón, Ilduara Pintos, Adrián Ferre Beltrán, Gustavo Centeno Soto, José Campos, Antonio Ramos Martínez, Cristina Avendaño-Solá, Ana Fernández Cruz |
X Demographics
The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 19% |
| United States | 5 | 19% |
| United Kingdom | 2 | 7% |
| Malaysia | 1 | 4% |
| New Zealand | 1 | 4% |
| Brazil | 1 | 4% |
| Unknown | 12 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 81% |
| Practitioners (doctors, other healthcare professionals) | 3 | 11% |
| Science communicators (journalists, bloggers, editors) | 2 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 67 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 10% |
| Other | 4 | 6% |
| Lecturer | 4 | 6% |
| Student > Doctoral Student | 4 | 6% |
| Student > Bachelor | 4 | 6% |
| Other | 15 | 22% |
| Unknown | 29 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 25% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Nursing and Health Professions | 3 | 4% |
| Agricultural and Biological Sciences | 3 | 4% |
| Economics, Econometrics and Finance | 1 | 1% |
| Other | 6 | 9% |
| Unknown | 34 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2023.
All research outputs
#1,362,459
of 25,173,778 outputs
Outputs from Infectious Diseases and Therapy
#63
of 812 outputs
Outputs of similar age
#31,242
of 433,892 outputs
Outputs of similar age from Infectious Diseases and Therapy
#4
of 36 outputs
Altmetric has tracked 25,173,778 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 812 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,892 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.